📰 Brd Group News
Page 2 - Brd Group News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Brd Group. Real-time updates on events, politics, business and more.
July 17, 2023
This multi disciplinary Black femme storyteller uses theatre to shape the world.
April 30, 2023
New Delhi [India], April 26 (ANI/GPRC): The Grand Technology Roadshow & Business Conclave 2023 was organised by ERD Group on April 25th and 26th in the National Capital, and dealers & distributors from all over India participated in the event. Pioneer in the manufacturing of mobile phone accessories in India, ERD Group, marking the 26th anniversary of the organisation, organised a 2-day grand business conference and technology exhibition. 600 plus dealers from Maharashtra, Karnataka, Tam...
October 14, 2022
The new work is by Jaime Lozano and Nancy Nachama Cheser.
September 1, 2022
2merkato provides business information for investors, suppliers, buyers, traders who are engaged or want to engage in business activities in Ethiopia.
August 6, 2022
Analyzing the clinical characteristics of patients tested for serum IgG4 because of suspecting IgG4-RD for a better understanding of the specific disorder.
August 2, 2022
Abingdon Theatre Company has announced two new Artists in Residence for their upcoming 30th Season beginning in the fall. Reynaldo Piniella and Pierre Marais are set to be the next participants in the Carolyn Halpert Artist in Residence Program, which began in 2017.
July 14, 2022
A new joint research centre to tackle key challenges in decarbonisation and climate repair is to be launched by Imperial College London and Hitachi. Imperial College London, Hitachi Ltd and Hitachi Europe Ltd have signed an agreement to create the Hitachi and Imperial Centre for Decarbonisation and Natural Climate Solutions, to collaborate in fundamental and applied research to drive the transition to net zero pollution.
July 1, 2022
Investegate announcements from Centessa Pharmaceuticals plc, Centessa Pharmaceuticals Announces Appointment of Dr. Mathias Hukkelhoven to its Board of Directors
July 1, 2022
BOSTON and LONDON, July 01, 2022 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company with a Research & Development ("R&D") innovation engine that aims